RAPT240719C5000
- 0.10
- 0.000.00%
RAPT Therapeutics Newsroom
Should You Sell Your Stake in RAPT Therapeutics (RAPT)?
Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
12 Health Care Stocks Moving In Monday's After-Market Session
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Wolfe Downgrades RAPT, but Still Sees "Immense" Upside Potential
Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
RAPT Falls for Second Day as Guggenheim, Barclays Downgrade Stock
Maintaining Hold Rating on RAPT Therapeutics Amid Clinical Uncertainties and Financial Outlook
Express News | RAPT Therapeutics Inc : Guggenheim Cuts to Neutral Rating
Express News | Guggenheim Downgrades RAPT Therapeutics to Neutral
RAPT Therapeutics Analyst Ratings
Express News | RAPT Therapeutics Inc : Barclays Cuts to Equal Weight From Overweight; Cuts Target Price to $4 From $13
US Equity Markets Close Higher Thursday as Jobless Claims Climb
Sector Update: Health Care
RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session